Literature DB >> 9506766

Mutation/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients.

I Yoshiuchi1, R Shingu, H Nakajima, T Hamaguchi, Y Horikawa, T Yamasaki, T Oue, A Ono, J I Miyagawa, M Namba, T Hanafusa, Y Matsuzawa.   

Abstract

Glucose-6-phosphatase (G6Pase) catalyzes the rate-limiting step of gluconeogenesis, and hepatic G6Pase activity is increased in diabetes. We have cloned and analyzed the human G6Pase gene promoter region and identified putative regulatory sequences for insulin, cAMP, glucocorticoid, and hepatocyte nuclear factors. The promoter region of the G6Pase gene was analyzed in 154 noninsulin-dependent diabetes mellitus patients and 90 control subjects by PCR-single strand conformation polymorphism and direct sequencing methods. Polymorphisms were not found in any subjects. The results suggested that in noninsulin-dependent diabetic patients, the major cause of the hepatic glucose overproduction was not attributed to dysregulation of the G6Pase gene due to mutation/polymorphism of its promoter region.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506766     DOI: 10.1210/jcem.83.3.4659

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.

Authors:  Heike Schäcke; Arndt Schottelius; Wolf-Dietrich Döcke; Peter Strehlke; Stefan Jaroch; Norbert Schmees; Hartmut Rehwinkel; Hartwig Hennekes; Khusru Asadullah
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

Review 2.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

3.  Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids.

Authors:  Christina Cicerchi; Nanxing Li; James Kratzer; Gabriela Garcia; Carlos A Roncal-Jimenez; Katsuyuki Tanabe; Brandi Hunter; Christopher J Rivard; Yuri Y Sautin; Eric A Gaucher; Richard J Johnson; Miguel A Lanaspa
Journal:  FASEB J       Date:  2014-04-22       Impact factor: 5.191

4.  Metabolic effects of prazosin on skeletal muscle insulin resistance in glucocorticoid-treated male rats.

Authors:  Emily C Dunford; Erin R Mandel; Sepideh Mohajeri; Tara L Haas; Michael C Riddell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-09       Impact factor: 3.619

5.  VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.

Authors:  Christopher R Heier; Jesse M Damsker; Qing Yu; Blythe C Dillingham; Tony Huynh; Jack H Van der Meulen; Arpana Sali; Brittany K Miller; Aditi Phadke; Luana Scheffer; James Quinn; Kathleen Tatem; Sarah Jordan; Sherry Dadgar; Olga C Rodriguez; Chris Albanese; Michael Calhoun; Heather Gordish-Dressman; Jyoti K Jaiswal; Edward M Connor; John M McCall; Eric P Hoffman; Erica K M Reeves; Kanneboyina Nagaraju
Journal:  EMBO Mol Med       Date:  2013-09-09       Impact factor: 12.137

6.  Mechanisms of action of topical corticosteroids in psoriasis.

Authors:  Luís Uva; Diana Miguel; Catarina Pinheiro; Joana Antunes; Diogo Cruz; João Ferreira; Paulo Filipe
Journal:  Int J Endocrinol       Date:  2012-11-05       Impact factor: 3.257

7.  Expression and Significance of N-myc downstream regulated gene 2 in the process of Esophageal Squamous Cell Carcinogenesis.

Authors:  Rui-Bing Feng; Qiao-Zhi Zhou; Rui Cheng; Peng Li; Sheng-Tao Zhu; Li Min; Shu-Tian Zhang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.